IP Library Granted Patent US 9,643,989
Granted Patent B2
US 9,643,989 · App. 14/267,455 · Granted May 9, 2017

Methods for preparing ruthenium carbene complex precursors and ruthenium carbene complexes

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,643,989
App. No.
14/267,455
Granted
May 9, 2017
Kind
B2
Abstract

A method for preparing a ruthenium carbene complex precursor includes reacting a ruthenium refinery salt with a hydrogen halide to form a ruthenium intermediate, and reacting the ruthenium intermediate with an L-type ligand to form the ruthenium carbene complex precursor. A method for preparing a ruthenium vinylcarbene complex includes converting a ruthenium carbene complex precursor into a ruthenium hydrido halide complex, and reacting the ruthenium hydrido halide complex with a propargyl halide to form the ruthenium vinylcarbene complex. A method for preparing a ruthenium carbene complex includes converting a ruthenium carbene complex precursor into a ruthenium carbene complex having a structure (PR 1 R 2 R 3 ) 2 Cl 2 Ru═CH—R 4 , wherein R 1 , R 2 , R 3 , and R 4 are alike or different, and wherein covalent bonds may optionally exist between two or more of R 1 , R 2 , and R 3 .

Claims (24)

1. A method of preparing a MX 2 L q complex comprising:

reacting a ruthenium (IV) hexahalo complex that comprises a [RuX 1 y X 2 6−y ] 2− anion with an L-type ligand to form the MX 2 L q complex;

wherein M is ruthenium;

wherein X 1 and X 2 are halogen atoms that are independently selected from the group consisting of Cl and Br;

wherein X is a halogen atom selected from the group consisting of Cl and Br;

wherein y is an integer value from 1 to 6; and

wherein q is 3.

2. The method of claim 1 wherein the L-type ligand is selected from the group consisting of olefins, phosphines, phosphites, amines, CO, N 2 , and combinations thereof.

3. The method of claim 2 , wherein the L-type ligand is selected from the group consisting of olefins, phosphines, and combinations thereof.

4. The method of claim 1 , wherein the L-type ligand comprises a phosphine.

5. The method of claim 4 , wherein the L-type ligand comprises a phosphorous-containing ligand having a structure PR 1 R 2 R 3 ;

wherein R 1 , R 2 , and R 3 are alike or different and are each independently selected from the group consisting of substituted or unsubstituted aryl, substituted or unsubstituted C 1 -C 10 alkyl, substituted or unsubstituted aryloxy, substituted or unsubstituted C 1 -C 10 alkoxy, and combinations thereof; and

wherein covalent bonds may optionally exist between two or more of R 1 , R 2 , and R 3 , such that when two or more of R 1 , R 2 , and R 3 are taken together, a bidentate ligand to phosphorous is formed.

6. The method of claim 5 , wherein the phosphorous-containing ligand is triphenyl phosphine.

7. The method of claim 4 , further comprising replacing one or more L-type ligands of the MX 2 L q complex with an N-heterocyclic carbene ligand to form an N-heterocyclic carbene-containing ruthenium carbene complex.

8. The method of claim 4 , further comprising replacing a phosphorous-containing ligand of the MX 2 L q complex with an imidazolidine ligand to form an imidazolidine-containing ruthenium carbene complex.

9. The method of claim 5 , further comprising replacing one or more L-type ligands of the MX 2 L q complex with an N-heterocyclic carbene ligand to form an N-heterocyclic carbene-containing ruthenium carbene complex.

10. The method of claim 5 , further comprising replacing a phosphorous-containing ligand of the MX 2 L q complex with an imidazolidine ligand to form an imidazolidine-containing ruthenium carbene complex.

11. The method of claim 6 , further comprising replacing one or more L-type ligands of the MX 2 L q complex with an N-heterocyclic carbene ligand to form an N-heterocyclic carbene-containing ruthenium carbene complex.

12. The method of claim 6 , further comprising replacing a phosphorous-containing ligand of the MX 2 L q complex with an imidazolidine ligand to form an imidazolidine-containing ruthenium carbene complex.

13. The method of claim 1 , wherein the ruthenium (IV) hexahalo complex comprises a [RuCl 6 ] 2− anion.

14. The method of claim 4 , wherein the ruthenium (IV) hexahalo complex comprises a [RuCl 6 ] 2− anion.

15. The method of claim 1 , wherein the ruthenium (IV) hexahalo complex comprises one or more ammonium cations.

16. The method of claim 4 , wherein the ruthenium (IV) hexahalo complex comprises one or more ammonium cations.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 15, 2020
From: ELEVANCE RENEWABLE SCIENCES, INC.
To: WILMAR TRADING PTE LTD
Reel/Frame 052942/0933 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 20, 2014
From: KUNZ, LINDA A.; COHEN, STEVEN A.; LUETKENS, MELVIN L., JR
To: ELEVANCE RENEWABLE SCIENCES, INC.
Reel/Frame 033979/0181 →